Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportInstrumentation & Data Analysis

Validation of an integrated, ultra-rapid 15O-PET system for quantitative assessment of CMRO2, CBF and OEF

Yuki Hori, Tetsuaki Moriguchi, Kazuhiro Koshino, Nobuyuki Kudomi, Naomi Morita, Kazunori Toyoda, Koji Iihara, Jyoji Nakagawara and Hidehiro Iida
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 207;
Yuki Hori
1Dept Investigative Radiol, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuaki Moriguchi
1Dept Investigative Radiol, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Koshino
1Dept Investigative Radiol, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuyuki Kudomi
2Dept Nuclear Medicine, Kagawa University School of Medicine, Takamatsu City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi Morita
3Hospital, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazunori Toyoda
3Hospital, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koji Iihara
3Hospital, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jyoji Nakagawara
3Hospital, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidehiro Iida
1Dept Investigative Radiol, NCVC, Suita City, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

207

Objectives Use of 15O2 and PET can provide essential information to characterize pathophysiological status in patients withCVD, but has limited applicability, due to complexed logistics. A novel system has been developed for ultra-rapid assessment of CMRO2, CBF and OEF, involving 15O-dedicated cyclotron, fully-automated radio-synthesis , and a dedicated workstation connected to peripheral devices, allowing easier operation under “on-demand” needs. We intended to evaluate feasibility of this system.

Methods Subjects consisted of 11 healthy volunteers (23.1±1.2 yo, all male) and 20 patients with steno/occlusive ICA, and 8 with Moyamoya diseases. A single dynamic PET scan was initiated over 9 min usingCTPET with continuous monitoring of arterial input function, while sequential inhalation of (15O2 and C15O2. Functional images of CMRO2, CBF, OEF, and CBV-equivalent V0’s for oxygen and water were calculated by the recently validated DBFM method (JCBFM, 2013). All subjects were scanned also with C15O to determine CBV. Results from DBFM were compared with those by DARG (JCBFM, 2005) with a standard CBV compasation. In normal, the short dynamic scan was repeated twice to evaluate reproducibility.

Results CBF, CMRO2 and OEF values from normal were 39±4.3 mL/min/100g, 3.4±0.30 mL/min/100g and 0.45±0.045, with reproducibility of +5.3±10, -10±9, -16±13% (mean±SD), respectively. Agreement of DBFM involving intrinsic CBV correction with DARG requiring additional CBV was 5.2±4.6, -4.9±6.5, and 0.1±5.7% in normal, corresponding to CBF, CMRO2 and OEF, respectively, and all <10%. Agreement was worse in patient populations, and was -6.5±8.1, 8.8±12.0, and -1.6±7.7%, respectively. Six cases in Moyamoya and 2 cases with steno-occlusive patients showed disagreement >10%.

Conclusions Results suggest validity of the present ultra-rapid, automated systemwith much improved logistics.

Research Support Grant from the Ministry of Health, Labour and Welfare, Japan (H22NIG002).

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation of an integrated, ultra-rapid 15O-PET system for quantitative assessment of CMRO2, CBF and OEF
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Validation of an integrated, ultra-rapid 15O-PET system for quantitative assessment of CMRO2, CBF and OEF
Yuki Hori, Tetsuaki Moriguchi, Kazuhiro Koshino, Nobuyuki Kudomi, Naomi Morita, Kazunori Toyoda, Koji Iihara, Jyoji Nakagawara, Hidehiro Iida
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 207;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Validation of an integrated, ultra-rapid 15O-PET system for quantitative assessment of CMRO2, CBF and OEF
Yuki Hori, Tetsuaki Moriguchi, Kazuhiro Koshino, Nobuyuki Kudomi, Naomi Morita, Kazunori Toyoda, Koji Iihara, Jyoji Nakagawara, Hidehiro Iida
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 207;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Instrumentation & Data Analysis

  • Exploring the impact of feature selection methods and classification algorithms on the predictive performance of PET radiomic ML models in lung cancer
  • Accuracy of 177Lu-DOTATATE PRRT absorbed dose estimation by reducing the imaging points
  • Assessment of AI-Enhanced Quantitative Volumetric MRI with Semi-Quantitative Analysis in 18F-FDG Metabolic Imaging for Alzheimer's Diagnosis.
Show more Instrumentation & Data Analysis

Data Analysis & Management I: Brain

  • Evaluation of experimental protocols to accurately measure α4β2* nicotinic acetylcholine receptor density with 18F-nifene
  • Human PET studies with [18F]PF-05270430, a PET radiotracer for imaging phosphodiesterase-2A
Show more Data Analysis & Management I: Brain

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire